• 1
    Okuda K. Hepatocellular carcinoma. J. Hepatol. 2000; 32 (Suppl.): S22537.
  • 2
    El-Serag HB & Mason AC. Risk factors for the rising rates of primary liver cancer in the United States. Arch. Intern. Med. 2000; 160: 332730.
  • 3
    Lin DY, Lin SM, Liaw YF. Non-surgical treatment of hepatocellular carcinoma. J. Gastroenterol. Hepatol. 1997; 12 (Suppl.): S31928.
  • 4
    Sheu JC, Sung JL, Chen DS et al. Early detection of hepatocellular carcinoma by real-time ultrasonography. Cancer 1985; 56: 6606.
  • 5
    Liaw YF, Tai DY, Chu CM et al. Early detection of hepatocellular carcinoma in patients with type B hepatitis. A prospective study. Gastroenterology 1986; 90: 2637.
  • 6
    Tanaka S, Kitamura T, Nakanishi K et al. Effectiveness of periodic check up by ultrasonography for the early diagnosis of hepatocellular carcinoma. Cancer 1990; 66: 221014.
  • 7
    Okazaki N, Yoshino M, Yoshida T et al. Early diagnosis of hepatocellular carcinoma. Hepatogastroenterology 1990; 37: 4803.
  • 8
    Oka H, Korioka N, Kim K. Prospective study of early detection of hepatocellular carcinoma in patients with cirrhosis. Hepatology 1990; 12: 6807.
  • 9
    Mima S, Sekiya C, Kanagawa H et al. Mass screening for hepatocellular carcinoma: experience in Hokkaido, Japan. J. Gastroenterol. Hepatol. 1994; 9: 3615.
  • 10
    Kato Y, Nakata K, Omagari K et al. Risk of hepatocellular carcinoma in patients with cirrhosis in Japan. Cancer 1994; 74: 22348.
  • 11
    Hung YT, Lin DY, Chiu CT. Risk factors of hepatocellular carcinoma with familial tendency. Chang Gung Med. J. 1995; 18: 813.
  • 12
    Takano S, Yokosuka O, Imazeki F, Tagawa M, Omata M. Incidence of hepatocellular carcinoma in chronic hepatitis B and C: a prospective study of 251 patients. Hepatology 1995; 21: 6505.
  • 13
    Curley SA, Izzo F, Gallipoli A, De Bellis M, Cremona F, Parisi V. Identification and screening of 416 patients with chronic hepatitis at high risk to develop hepatocellular cancer. Ann. Surg. 1995; 222: 37583.
  • 14
    Sherman M, Peltekian KM, Lee C. Screening for hepatocellular carcinoma in chronic carriers of hepatitis B virus: incidence and prevalence of hepatocellular carcinoma in a North American urban population. Hepatology 1995; 22: 4328.
  • 15
    Dixon J, Fargion S, Conte D, Losowsky M, Powel L. Effectiveness of regular surveillence of hepatocellular carcinoma in haemochromatosis with cirrhosis. J. Gastroenterol. Hepatol. 1997; 12 (Suppl.): A50 (Abstract).
  • 16
    Giannini E, Arzani L, Borre P et al. Efficacy of surveillance for hepatocellular carcinoma in HCV cirrhotic patients. J. Hepatol. 1999; 30 (Suppl. 1): 212 (Abstract).
  • 17
    Chiaramonte M, Stroffolini T, Vian A et al. Rate of incidence of hepatocellular carcinoma in patients with compensated viral cirrhosis. Cancer 1999; 85: 21327.
  • 18
    McMahon BJ, Bulkow L, Harpster A et al. Screening for hepatocellular carcinoma in Alaska natives infected with chronic hepatitis B: a 16-year population-based study. Hepatology 2000; 32: 8426.
  • 19
    Tong MJ, Blatt LM, Kao VWC. Surveillance for hepatocellular carcinoma in patients with chronic viral hepatitis in the United States of America. J. Gastroenterol. Hepatol 2001; 16: 5539.DOI: 10.1046/j.1440-1746.2001.02470.x
  • 20
    Liaw YF, Tai DI, Chen TJ, Chu CM, Huang MJ. Alpha-fetoprotein changes in the course of chronic hepatitis: relation to bridging hepatic necrosis and hepatocellular carcinoma. Liver 1986; 6: 1337.
  • 21
    Germa-Lluch JR, Regent RHJ, Bagshawe KD. Tumor-marker levels and prognosis in malignant teratoma of testis. Br. J. Cancer 1980; 42: 8505.
  • 22
    Aoyagi Y, Isokawa O, Suda T et al. The fucosylation index of alpha-fetoprotein as a possible prognostic indication for patients with hepatocellular carcinoma. Cancer 1998; 83: 207682.
  • 23
    Chen DS, Sung JL, Sheu JC et al. Serum alpha fetoprotein in the early stage of human hepatocellular carcinoma. Gastroenterology 1984; 86: 14049.
  • 24
    Sheu JC, Sung JL, Chen DS et al. Growth rate of symptomatic hepatocellular carcinoma and its clinical implications. Gastroenterology 1985; 89: 25966.
  • 25
    Tarao K, Rino Y, Ohkawa S et al. Association between high serum alanine aminotransferase levels and more rapid development and higher rate of incidence of hepatocellular carcinoma in patients with hepatitis C virus-associated cirrhosis. Cancer 1999; 86: 58995.
  • 26
    Kang JY, Lee TP, Yap I, Lun KC. Analysis of cost-effectiveness of different strategies for hepatocellular carcinoma screening in hepatitis B virus carriers. J. Gastroenterol. Hepatol. 1992; 7: 4638.
  • 27
    Namieno T, Kawata A, Sato N, Kondo Y, Uchino J. Age-related, different clinicopathologic features of hepatocellular carcinoma patients. Ann. Surg. 1995; 221: 30814.
  • 28
    Collier J & Sherman M. Screening for hepatocellular carcinoma. Hepatology 1998; 27: 2738.